Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 23 studies | 29% ± 10% | |
myofibroblast cell | 8 studies | 22% ± 9% | |
astrocyte | 8 studies | 27% ± 12% | |
smooth muscle cell | 7 studies | 21% ± 4% | |
connective tissue cell | 7 studies | 26% ± 8% | |
pericyte | 6 studies | 19% ± 2% | |
endothelial cell | 5 studies | 19% ± 2% | |
amacrine cell | 5 studies | 37% ± 11% | |
retinal ganglion cell | 4 studies | 51% ± 29% | |
retina horizontal cell | 4 studies | 39% ± 6% | |
adventitial cell | 4 studies | 27% ± 18% | |
melanocyte | 4 studies | 48% ± 12% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 10% | |
neuron | 3 studies | 27% ± 9% | |
retinal bipolar neuron | 3 studies | 28% ± 6% | |
GABAergic amacrine cell | 3 studies | 36% ± 12% | |
glycinergic amacrine cell | 3 studies | 25% ± 10% | |
kidney loop of Henle epithelial cell | 3 studies | 27% ± 10% | |
Mueller cell | 3 studies | 38% ± 5% | |
GABAergic neuron | 3 studies | 35% ± 7% | |
glutamatergic neuron | 3 studies | 42% ± 11% | |
oligodendrocyte | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6635.40 | 245 / 245 | 100% | 120.66 | 501 / 502 |
brain | 100% | 7688.81 | 2636 / 2642 | 100% | 121.88 | 703 / 705 |
ovary | 100% | 11307.88 | 180 / 180 | 99% | 72.77 | 426 / 430 |
breast | 100% | 7166.74 | 459 / 459 | 97% | 85.29 | 1083 / 1118 |
liver | 98% | 3501.93 | 221 / 226 | 96% | 76.54 | 390 / 406 |
skin | 95% | 4023.87 | 1717 / 1809 | 99% | 109.18 | 466 / 472 |
adrenal gland | 98% | 7390.69 | 253 / 258 | 95% | 58.98 | 219 / 230 |
kidney | 100% | 4679.22 | 89 / 89 | 93% | 71.98 | 835 / 901 |
thymus | 99% | 4917.31 | 647 / 653 | 85% | 40.90 | 516 / 605 |
uterus | 100% | 9564.55 | 170 / 170 | 83% | 41.46 | 379 / 459 |
pancreas | 85% | 1766.22 | 278 / 328 | 93% | 41.76 | 166 / 178 |
lung | 92% | 3404.14 | 531 / 578 | 80% | 31.29 | 919 / 1155 |
bladder | 95% | 6056.62 | 20 / 21 | 66% | 25.01 | 332 / 504 |
stomach | 100% | 4653.75 | 358 / 359 | 41% | 11.01 | 118 / 286 |
intestine | 93% | 5726.13 | 898 / 966 | 34% | 9.78 | 178 / 527 |
esophagus | 85% | 4332.03 | 1234 / 1445 | 32% | 8.38 | 59 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 295.30 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.87 | 1 / 1 |
blood vessel | 100% | 7787.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 6100.08 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 5289.20 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 5222.56 | 833 / 861 | 0% | 0 | 0 / 0 |
spleen | 95% | 3143.34 | 229 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 31.44 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 5.92 | 6 / 29 |
peripheral blood | 1% | 15.43 | 8 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019886 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005615 | Cellular component | extracellular space |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005886 | Cellular component | plasma membrane |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
Gene name | CTSF |
Protein name | CTSF protein Cathepsin F Cathepsin F (CATSF) (EC 3.4.22.41) |
Synonyms | hCG_20245 |
Description | FUNCTION: Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis. |
Accessions | A0A7I2V313 ENST00000524994.6 A0A7I2V5Q1 ENST00000677005.1 ENST00000679160.1 ENST00000678953.1 ENST00000310325.10 ENST00000678872.1 A0A7I2V3L9 Q9UBX1 ENST00000678413.1 ENST00000677526.1 ENST00000679024.1 A0A7I2V3X1 A0A7I2V3E7 H0YE42 ENST00000676924.1 ENST00000678154.1 A0A7I2V5B9 ENST00000525733.6 ENST00000678710.1 A0A7I2V3M3 A0A7I2V5F8 ENST00000677896.1 A0A7I2V411 A0A7I2V4A8 A0A7I2YQH8 A0A7I2YQW3 ENST00000526010.2 A0A7I2V4V5 ENST00000677587.1 H0YD65 A0A7I2V3V9 A0A7I2YQB3 ENST00000678471.1 ENST00000678305.1 ENST00000677920.1 A0A7I2V2K3 Q6FHS1 ENST00000679347.1 ENST00000679314.1 A0A7I2YQ73 A0A024R5G9 ENST00000679011.1 |